On risks and benefits of iron supplementation recommendations for iron intake revisited

Journal of Trace Elements in Medicine and Biology

Volumn 21, Issue 3, 2007, Pages 147-168

  Schümann, Klaus ^a   Ettle, Thomas ^b   Szegner, Bernadett ^a   Elsenhans, Bernd ^c   Solomons, Noel W ^d  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Physiology of Nutrition   (Austria)

^c UNIVERSITY OF MUNICH   (Germany)

^d Center for Studies of Sensory Impairment Aging and Metabolism Guatemala   (Guatemala)

Author keywords

Benefits; Iron; Recommended dietary allowance; Risk; Supplementation

Indexed keywords

IRON;

ACUTE HEART INFARCTION; ANEMIA; CLINICAL TRIAL; COLITIS; COLON CARCINOGENESIS; COLORECTAL CARCINOMA; CONSTIPATION; DIARRHEA; DIETARY INTAKE; DOSE RESPONSE; DRUG DISTRIBUTION; DRUG OVERDOSE; EPIGASTRIC DISCOMFORT; FECES COLOR; HEART FAILURE; HEMOSIDEROSIS; HUMAN; INTESTINE INJURY; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON INTAKE; IRON OVERLOAD; IRON THERAPY; LACTATION; LIVER CELL CARCINOMA; LIVER FIBROSIS; MALARIA; MENINGITIS; META ANALYSIS; MUCOSAL DISEASE; NAUSEA; NONHUMAN; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PREGNANCY; PRIORITY JOURNAL; PUERPERIUM; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SEPSIS; SIDE EFFECT; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; VOMITING;

EID: 34547804359     PISSN: 0946672X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtemb.2007.06.002     Document Type: Review

References (201)

1. Andrews S.C., Robinson A.K., and Rodriguez-Quinones F. Bacterial iron homeostasis. FEMS Microbiol Rev 27 (2003) 215-237
2. McCord J.M. Iron, free radicals, and oxidative injury. Semin Hematol 35 (1998) 5-12
3. Osler M., Milman N., and Heitmann B.L. Consequences of removing iron fortification of flour on iron status among Danish adults: some longitudinal observation between 1987 and 1994. Prev Med 29 (1999) 32-36
4. DeMaeyer E., and Adiels-Tegman M. The prevalence of anemia in the world. World Health Stat Q 38 (1985) 302-316
5. Beard J.L., and Dawson H.D. Iron. In: O'Dell B.L., and Sunde R.A. (Eds). Handbook of nutritionally essential elements (1997), Marcel Dekker Inc., New York 334
6. WHO. The prevalence of anemia in women: a tabulation of available information. 2nd ed (1992), WHO, Geneva
7. Dewey K.G., Romero-Abal M.E., Quan de Serrano J., Bulux J., Peerson J.M., Engle P., et al. Effects of discontinuing coffee intake on iron status of iron-deficient Guatemalan toddlers: a randomized intervention study. Am J Clin Nutr 66 (1997) 168-176
8. In: Kübler W., Anders H.J., and Heeschen W. (Eds). VERA-Schriftenreihe. Eisenstatus, Band V (1995), Wissenschaflicher Fachverlag Dr. Fleck, Niederkleen B11-B110 [in German]
9. Dallman P.R. Manifestations of iron deficiency. Semin Hematol 19 (1982) 19-30
10. Grantham-McGregor S., and Ani C. A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 131 (2001) 649S-668S
11. Lozoff B., Jimenez E., and Wolf A.W. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 325 (1991) 687-694
12. Algarin C., Reirano P., Garrido M., Pizarro F., and Lozoff B. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr Res 53 (2003) 217-223
13. Connor J.R., and Menzies S.L. Relationship of iron to oligodendrocytes and myelination. GLIA 17 (1996) 83-93
14. Idjradinata P., Watkins W.E., and Politt E. Adverse effects of iron supplementation on weight gain of iron-replete young children. Lancet 343 (1994) 1252-1254
15. Politt E. The developmental and probalistic nature of the functional consequences of iron-deficiency anemia in children. J Nutr 131 (2001) 669S-675S
16. Allen L.H., Rosado J.L., Caserline J.E., Lopez P., Munoz E., Garcia O.P., et al. Lack of hemoglobin response to iron supplementation in anemic Mexican preschoolers with multiple micronutrient deficiencies. Am J Clin Nutr 71 (2000) 1485-1494
17. Baynes R.D., and Bothwell T.H. Iron deficiency. Annu Rev Nutr 10 (1990) 133-148
18. Greenwood R., Golding J., McCaw-Binns A., Keeling J., and Ashley D. The epidemiology of perinatal death in Jamaica. Paediatr Perinat Epidemiol 8 (1994) 143-157
19. Kalra L., Hamlyn A.N., and Jones B.J.M. Blue sclera: a common sign of iron-deficiency?. Lancet 2 (1986) 1267-1268
20. Dhur A., Galan P., and Hercberg S. Iron status, immuno capacity and resistance to infections. Comp Biochem Physiol 94 (1989) 11-19
21. Farthing M.J. Iron and immunity. Acta Paediatr Scand Suppl 361 (1989) 44-52
22. Herschko C. Iron, infection, and immune function. Proc Nutr Soc 52 (1993) 165-174
23. Scrimshaw N.S., and San Giovanni J.P. Synergism of nutrition, infection and immunity: an overview. Am J Clin Nutr 66 (1997) 464S-477S
24. Oppenheimer S.J. Iron and its relation to immunity and infectious diseases. J Nutr 131 (2001) 616S-635S
25. Crichton R. Inorganic biochemistry of iron metabolism. 2nd ed (2001), Wiley, Chichester
26. Kakhlon O., Gruenbaum Y., and Cabanchik Z.I. Repression of the heavy ferritin chain increases the labile iron pool in human K562 cells. Biochem J 356 (2001) 311-316
27. Epzstejn S., Glickstein H., Picard U., Slotki I.N., Breuer W., Beaumont C., et al. H-ferritin subunit over-expression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94 (1999) 3593-3603
28. Seril D.N., Liao J., Ho K.L.K., Wars A., Yang C.S., and Yang G.-Y. Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 47 (2002) 1266-1278
29. Telfer J.F., and Brock J.H. Expression of ferritin, transferrin receptor and non-specific resistance associated macrophage proteins 1 and 2 (Nramp 1 and Nramp 2) in the human rheumatoid synovium. Ann Rheum Dis 61 (2002) 741-744
30. Keusch G.T., and Farthing M.J. Nutrition and infection. Annu Rev Nutr 6 (1986) 131-154
31. Solomons N.W., Mazariegos M., Brown K.H., and Klasing K. The underprivileged developing country child: environmental contamination and growth resisted. Nutr Rev 61 (1993) 327-332
32. Majumdar I., Paul P., Talib V.H., and Ranga S. The effect of iron therapy on growth of iron-repleted and iron-depleted children. J Trop Pediatr 49 (2003) 84-88
33. Loyevsky M., John C., Dickens B., Hu V., Miller J.H., and Gordeuk V.R. Chelation of iron with the erythrocytic plasmodium falciparum parasite by iron chelators. Mol Biochem Parasitol 101 (1999) 43-59
34. Herschko C., Peto T.E.A., and Weatherall D.J. Iron and infection. Br Med J 296 (1988) 660-664
35. Canonne-Hergaux F., Gruenheid S., Govoni G., and Gros P. The NRAMP protein and its role in resistance to infection and macrophage function. Proc Soc Assoc Am Physicians 111 (1999) 283-289
36. Hentze M.W., Muckenthaler M.U., and Andrews N.C. Balancing acts: molecular control of mammalian iron metabolism. Cell 117 (2004) 285-297
37. Pantopoulos K., and Hentze M.W. Nitric oxide, oxygen radicals and iron metabolism. In: Ignarro L. (Ed). Nitric Oxide (2000), Academic Press, San Diego, CA 293-313
38. Sazawal S., Black R.E., Ramsan M., Chwaya H.M., Stoltzfus R.J., Dutta A., et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367 (2006) 133-143
39. Knutson M.D., Walter P.B., Ames B.N., and Viteri F.E. Both iron deficiency and daily iron supplementation increase lipid peroxidation in rats. J Nutr 130 (2000) 621-628
40. Knutson M.D., Walter P.B., Mendoza C., Ames B.N., and Viteri F.E. Effects of daily oral iron supplementation on iron status and lipid peroxidation in women. FASEB J 13 (1999) 698
41. Casanueva E., Viteri F.E., Mares-Galindo M., Meza-Camacho C., Loria A., Schnaas L., et al. Weekly iron as a safe alternative to daily supplementation for nonanemic pregnant women. Arch Med Res 37 (2006) 674-682
42. Rosales F.J., Kang Y., Pfeiffer B., Rau A., Romero-Abal M.-E., Erhardt J.G., et al. Twice the recommended daily allowance of iron is associated with an increase in plasma α-1 antichymotrypsin concentration in Guatemalan school-aged children. Nutr Res 24 (2004) 875-887
43. Schümann K., Kroll S., Weiss G., Frank J., Biesalski H.K., Daniel H., et al. Monitoring of haematological, inflammatory and oxidative reactions of acute oral iron exposure in human volunteers: preliminary screening for selection of potentially-responsive biomarkers. Toxicology 212 (2005) 10-23
44. Jacobs E.M.G., Hendriks J.C.M., von Tits B.L.J.H., Evan P.J., Breuer W., Lin D.Y., et al. Results on an international round robin for the quantification of serum non-transferrin-bound iron. Need for defining standardization and clinically relevant isoforms. Anal Biochem 341 (2005) 241-250
45. Simpson R.J., Cooper C.E., Raja K.B., Halliwell B., Evans P.J., Aruoma O.I., et al. Non-transferrin-bound iron species in serum of hypotransferrinaemic mice. Biochem Biophys Acta 1156 (1992) 19-26
46. Kooistra M.P., Kersting S., Gosriwatana I., Lu S., Nijhoff-Schutte J., Hider R.C., et al. Nontransferrin-bound iron in the plasma of haemodialysis patients after intravenous iron saccharate infusion. Eur J Clin Invest 32 Suppl. 1 (2002) 36-41
47. De Valk B., Leus F.R., Voorbij H.A., and Marx J.J. Iron does not bind to the Apo-B protein of low-density lipoprotein. Eur J Clin Invest 32 Suppl. 1 (2002) 17-20
48. Loreal O., Gosriwatana I., Guyader D., Porter J., Brissot P., and Hider R.C. Determination of non-transferrin-bound iron in genetic hemochromatosis using a new HPLC-based method. J Hepatol 32 (2000) 727-733
49. Hutchinson C., Al-Ashgar W., Liu D.Y., Hider R.C., Powell J.J., and Geissler C.A. Oral ferrous sulphate lease to a marked increase in pro-oxidant nontransferrin-bound iron. Eur J Clin Invest 34 (2004) 782-784
50. Hider R. Nature of nontransferrin-bound iron. Eur J Clin Invest 32 Suppl. 1 (2002) 50-54
51. Esposito B.P., Breuer W., Sirankapracha P., Pootrakul P., Hershko C., and Cabantchik Z.I. Labile plasma iron in iron overload: redox activity and susceptibility to chelation. Blood 102 (2003) 2670-2677
52. Chrisholm G.M., and Steinberg D. The oxidative modification hypothesis of atherogenesis: an overview. Free Radical Biol Med 28 (2000) 1815-1826
53. Van Tits L.J.H., Jacobs E.M.G., Swinkels D.W., Lemmers H.L.M., van der Vleuten G.M., de Graaf J., et al. Serum non-transferrin-bound iron and low density lipoproteins oxidation in heterozygous hemochromatosis. Biochem Biophys Res Commun 345 (2006) 371-376
54. Halle M., König D., Berg A., Keul J., and Baumstark M.W. Relationship of serum ferritin concentration with metabolic cardiovascular risk factors in men without evidence for coronary artery disease. Atherosclerosis 128 (1997) 235-240
55. Darley-Usmar V., and Halliwell B. Blood radicals: reactive nitrogen species, reactive oxygen species, transition metal ions, and the vascular system. Pharm Res 13 (1996) 649-662
56. Kartikasari E.R., Georgiou N.A., Visseren F.L.J., van Kats-Renaud H., can Asbeck B.S., and Marx J.J.M. Intracellular labile iron modulated adhesion of human monocytes to human endothelial cells. Arterioscler Thromb Vasc Biol 24 (2004) 2257-2262
57. Jeny V., Balla J., Yachie A., Varga Z., Vercellotti G.M., Eaton J.W., et al. Pro-oxidants and cytotoxic effects of circulating heme. Blood 100 (2002) 879-887
58. Yachi A., Niida Y., Wada T., Igarashi N., Kaneda H., Toma T., et al. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency. J Clin Invest 103 (1999) 129-135
59. Finch C. Regulators of iron balance in humans. Blood 84 (1994) 1697-1702
60. Frazer D.M., Wilkins S.J., Becker E.M., Murphy T.L., Vulpe C.D., McKie A.T., et al. A rapid decrease in the expression of DMT1 and Dcytb but not IRP1 or hephaestin explains the mucosal block phenomenon of iron absorption. Gut 52 (2003) 340-346
61. Hallberg L., Hulten L., and Gramatkovski E. Iron absorption from the whole diet in men: how effective is the regulation of iron absorption?. Am J Clin Nutr 66 (1997) 347-356
62. Fleming D.J., Tucker K.L., Jaques P.F., Dallal G.E., Wilson P.W.F., and Wood R.J. Dietary factors associated with the risk of high iron stores in the elderly Framingham heart study cohort. Am J Clin Nutr 76 (2002) 1375-1384
63. Shayeghi M., Latunde-Dada G.O., Oakhill J.S., Laftah A.H., Takeuchi K., Halliday N., et al. Identification of an intestinal heme transporter. Cell 122 (2005) 649-651
64. Qui A., Jansen M., Sakaris A., Min S.H., Chattopadhyay S., Tsai E., et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption. Cell 127 (2006) 917-928
65. Nemeth E., Tuttle M.S., Powelson J., Vaughn M.B., Donovan A., Ward D.M., et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306 (2004) 2090-2093
66. Kemna E., Pickkers P., Nemeth E., van der Hoeven H., and Swinkels D. Time-course analysis of hepcidin, serum iron and plasma cytokine levels in humans injected with LPS. Blood 106 (2005) 1864-1866
67. Nemeth E., Rivery S., Gabayan V., Keller C., Taudorf S., Pedersen B.K., et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113 (2004) 1271-1276
68. Lee P., Peng H., Gelbart T., Wang L., and Beutler E. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 102 (2005) 1906-1910
69. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
70. Silvestri L., Pagani A., Fazi C., Geradi G., Levi S., Arosio P., et al. Detective targeting of hemojuvelin to plasma membrane is a common pathogenetic mechanism in juvenile hemocromatosis. Blood 109 (2007) 4503-4510
71. Nairz M, Theurl I, Ludwiczek S, Theurl M, Mair SM, Fritsche G, et al. The coordinated regulation of iron homeostasis in murine macrophages limits the availability of iron for intracellular Salmonella typhimurium. Cell Microbiol 2007:e-pub ahead of print.
72. Papanikolaou G., and Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 202 (2005) 199-211
73. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodide, iron, manganese, molybdenum, nickel, silicon, vanadium and zinc (2001), National Academy Press, Washington, DC
74. UNICEF, Preventing iron deficiency in women and children, Technical workshop, New York, 1999. p. 13-7 [Chapter 2].
75. FAO/WHO (1988/revision 2004) Requirements of vitamin A, iron, folate and vitamin B12. FAO Food and Nutrition Series, No 23. Rome: FAO. p. 33-50 (revision 2004: p. 246-78).
76. Scientific Committee on Food of the European Commission. Opinion on food, on nutrition and energy intakes for the European Community, 1989. 〈http://ec.Europa.Eu/comm./food/fs/sc/scf/Out89.pdf〉.
77. Deutsche Gesellschaft für Ernährung. Referenzwerte für die Nährstoffzufuhr. 1st ed (2000), Umschau Braus GmbH, Frankfurt p. 174-8 [in German]
78. Nordic council. In: Oskarsson A, editor. Risk evaluation of essential trace elements, vol. 18. Copenhagen: Nord; 1995. p. 67-118.
79. Expert Group on Vitamins and Minerals. Safe upper levels for vitamins and minerals (2003), Food Standards Agency Publications, London
80. Cook J.D., Lipschitz D.A., Miles L.E., and Finch C.A. Serum ferritin as a measure of iron stores in normal subjects. Am J Clin Nutr 27 (1974) 681-687
81. Siimes M.A., Refino C., and Dallman P. Manifestation of iron deficiency at various levels of dietary iron intake. Am J Clin Nutr 33 (1980) 570-574
82. Siimes M.A., Refino C., and Dallman P. Physiological anemia of early development in the rat: Characterization of the iron-responsive component. Am J Clin Nutr 33 (1980) 2601-2608
83. Forth W., and Rummel W. Iron absorption. Physiol Rev 53 (1973) 724-792
84. Allen LH, Ahluwalia N. Improving iron status through diet. The application of knowledge concerning dietary iron bioavailability in human populations. OMNI Technical Papers, No. 8. John Snow International, Arlington, VA, 1997.
85. Fairweather-Tait S., Fox T., Wharf S.G., and Eagles J. The bioavailability of iron in different weaning foods and the enhancing effect of a fruit drink containing ascorbic acid. Pediatr Res 37 (1995) 389-394
86. Gillooly M., Bothwell T.H., Torrance J.D., MacPhail A.P., Derman D.P., Bezwoda W.R., et al. The effects of organic acids, phytates and polyphenols on the absorption of iron from vegetables. Br J Nutr 49 (1983) 331-342
87. Mulvihill B., Kirwan F.M., Morrissey P.A., and Flynn A. Effects of myofibrillar muscle protein on the in vitro bioavailability of non-haem iron. Int J Food Sci Nutr 49 (1998) 187-192
88. Cook J.D., Reddy M.B., Burri J., Juillerat M.A., and Hurrell R.F. The influence of different cereal grains on iron absorption from infant cereal foods. Am J Clin Nutr 65 (1997) 964-969
89. Hurrell R.F., Juillerat M.A., Reddy M.B., Lynch S.R., Dassenko S.A., and Cook J.D. Soy protein, phytate and iron absorption in humans. Am J Clin Nutr 56 (1992) 573-578
90. Disler P.B., Lynch S.R., Charlton R.W., Torrance J.D., Bothwell T.H., Walker R.B., et al. The effect of tea on iron absorption. Gut 16 (1975) 193-200
91. Hallberg L., Brune M., Erlandsson M., Sandberg A.S., and Rossander-Hulthen L. Calcium: effect of different amounts of nonheme- and heme-iron absorption in humans. Am J Clin Nutr 53 (1991) 112-119
92. Hallberg L., Rossander-Hulthen L., Brune M., and Gleerup A. Inhibition of heam-iron absorption in man by calcium. Br J Nutr 69 (1993) 533-540
93. Ettle T., Elsenhans B., Windisch W., Srai S.K.S., and Schümann K. Mobilisation of recently absorbed 59Fe in ex vivo perfused rat duodenal and the influence of iron status and subsequently absorbed chelators. J Trace Elem Med Biol 19 (2005) 231-241
94. Cook J.D., Dassenko S.A., and Lynch S.R. Assessment of the role of nonheme-iron availability in iron balance. Am J Clin Nutr 54 (1991) 717-722
95. Taylor P.G., Mendez-Castellanos H., Martinez-Torres C., Jaffe W., Lopez de Blanco M., Landaeta-Jimenez M., et al. Iron bioavailability from diets consumed by different socioeconomic strata of the Venezuelan population. J Nutr 25 (1995) 1860-1868
96. Hallberg L., Rossander L., Hulten L., Brune M., and Gleerup A. Inhibition of haem-iron absorption in men by calcium. Br J Nutr 69 (1992) 533-540
97. Monsen E.R., Hallberg L., Layrisse M., Hegsted M., Cook J.D., Merz W., et al. Estimation of available dietary iron. Am J Clin Nutr 31 (1978) 134-141
98. Davidsson L., Galan P., Cherouvrier F., Kastenmayer P., Juillerat M.A., Hercberg S., et al. Bioavailability in infants of iron from infant cereals: effect of dephytinization. Am J Clin Nutr 65 (1997) 916-920
99. Green R., Charlton R., Seftel H., Bothwell T., Mayet F., Adams B., et al. Body iron excretion in man: a collaborative study. Am J Med 45 (1968) 336-353
100. Beaton G.H., Corey P.N., and Steeles C. Conceptual and methodological issues regarding the epidemiology of iron deficiency and their implications for studies of the functional consequences of iron deficiency. Am J Clin Nutr 50 (1989) 575-588
101. Bothwell T.H., Charlton R.W., Cook J.D., and Finch C.A. Internal iron kinetics. Iron metabolism in man (1979), Blackwell Scientific Publishers, London, Oxford 327-353
102. Hytten F.E., and Leitch I. The physiology of human pregnancy. 2nd ed (1971), Blackwell Scientific, Oxford
103. Barrett J.F., Whittaker P.G., Williams J.G., and Lind T. Absorption of non-haem iron from food during normal pregnancy. Br Med J 309 (1994) 79-82
104. Hallberg L. Iron balance in pregnancy. In: Berger H. (Ed). Vitamins and minerals in pregnancy and lactation. Nestle Nutrition Workshop Series vol. 16 (1988), Raven Press, New York, NY 115-127
105. Garby L., Sjolin S., and Vuille J.C. Studies on erythro-kinetics in infancy. IV. The long-term behaviour of radioiron in circulating foetal and adult haemoglobin and its faecal excretion. Acta Paediatr Scand 53 (1964) 33-41
106. Dibley M.J., Goldsby J.B., Staehling N.W., and Trowbridge F.L. Development of normalized curves for the international growth reference: historical and technical considerations. Am J Clin Nutr 46 (1987) 736-748
107. Hawkins W.W. Iron, copper and cobalt. In: Beaton G.H., and McHenry E.W. (Eds). Nutrition: a comprehensive treatise (1964), Academic Press, New York 309-372
108. Smith N.J., and Rios E. Iron metabolism and iron deficiency in infancy and childhood. Adv Pediatr 21 (1974) 239-280
109. Dallman P.R. Iron deficiency in the weanling: a nutritional problem on the way to resolution. Acta Paediatr Scand Suppl 323 (1986) 59-67
110. Abrams S.A., Wen J., and Stuff J.E. Absorption of calcium, zinc, and iron from breast milk by five- to seven-month-old infants. Pediatr Res 41 (1997) 384-390
111. Davidsson L., Kastenmayer P., Szajewska H., Hurrell R.F., and Barclay D. Iron bioavailability in infants from an infant cereal fortified with ferric pyrophosphate or ferrous fumarate. Am J Clin Nutr 71 (2000) 1597-1607
112. Skinner J.D., Carruth B.R., Houck K.S., Coletta F., Cotter R., Ott D., et al. Longitudinal study of nutrient and food intakes of infants aged 2 to 24 months. J Am Diet Assoc 97 (1997) 496-504
113. Haycock G.B., Schwartz G.J., and Wisotsky D.H. Geometric method for measuring body surface area: a height-weight formula validated in infants, children, and adults. J Pediatr 93 (1978) 62-66
114. Frisancho A.R. Anthropometric standards for the assessment of growth and nutritional status (1990), University of Michigan Press, Ann Arbor
115. Hallberg L., Hogdahl A.M., Nilsson L., and Rybo G. Menstrual blood loss and iron deficiency. Acta Med Scand 180 (1966) 639-650
116. Monsen E.R. Iron nutrition and absorption: dietary factors which impact iron bioavailability. J Am Diet Assoc 88 (1988) 786-790
117. Vijayaraghavan K. Control of micronutrient deficiencies in India: obstacles and strategies. Nutr Rev 60 (2002) S73-S76
118. Sharma J.B., Jain S., and Mallika V. A prospective, partially randomised study of pregnancy outcomes and haematological responses to oral and intramuscular iron treatment in moderately anemic pregnant women. Am J Clin Nutr 79 (2004) 116-122
119. In: Solomons N.W., and Schümann K. (Eds). Intramuscular iron dextrane is not appropriate for moderate anemia of pregnancy: not in intervention research on underprivileged women, and never in routine public health care. Am J Clin Nutr 79 (2004) 1-3
120. Renwick A.G., Flynn A., Fletcher R.J., Müller D.J.G., Tuijelaars S., and Verhagen H. Risk-benefit analysis of micronutrients. Food Chem Toxicol 42 (2004) 1903-1922
121. Domke A., Großkalus R., Niemann B., Pzyrembel H., Richter K., Schmidt E., et al. Use of minerals in foods, toxicological and nutritional-physiological aspects (part II) (2006), Federal Institute for Risk Assessment, Berlin p. 145-88
122. Ellenham M.J., and Barceloux D.G. Iron. Medical toxicology (1988), Elsevier, New York, Amsterdam, London 1023-1030
123. Berenbaum M.C., Child K.J., Davis K.L., Sharpe H.M., and Tomich E.G. Animal and human studies on ferrouse fumarate, an oral hematinic. Blood 15 (1960) 540-550
124. Whittaker P., Dunkel V.C., Bucci T.J., Kusewitt D.F., Thurman J.D., Warbritton A., et al. Genome-linked toxicity responses to dietary iron overload. Toxicol Pathol 25 (1997) 556-564
125. Fleming R.E., Holden C.C., Tomatsu S., Warheed A., Brunt E.M., Britton R.S., et al. Mouse strain differences determine severity of iron accumulation in Hfe knockout model of hereditary hemochromatosis. PNAS 98 (2001) 2707-2711
126. Lebeau A., Frank J., Biesalski H.K., Weiss G., Srai S.K.S., Simpson R.J., et al. Long-term sequels of HFE deletion on C57BL/6x 129/O1a mice, an animal model for hereditary haemochromatosis. Eur J Clin Invest 32 (2002) 603-612
127. Anderson A.C. Iron poisoning in children. Curr Opin Pediatr 6 (1994) 289-294
128. Brock C., Curry H., Hama C., Knipfer M., and Taylor L. Adverse effects of iron supplementation: a comparative trial of wax-matrix iron preparation and conventional ferrous sulfate tablets. Clin Ther 7 (1985) 568-573
129. Choplin M., Schuette S., Leichtmann G., and Lasher B. Tolerability of iron: a comparison of bis-glycino iron(II) and ferrous sulphate. Clin Ther 13 (1991) 606-612
130. Frykman E., Bystrom M., Jansson U., Edberg A., and Hansen T. Side effects of iron supplements in blood donors: superior tolerance of heme iron. J Lab Clin Med 123 (1994) 561-564
131. Ganzoni A.M., Töndung G., and Rhymer K. Orale Eisenmedikation. Dtsch Med Wochenschr 99 (1974) 1175-1178 [in German]
132. Liguori L. Iron protein succinylate in the treatment of iron deficiency: controlled, double blind, multicenter clinical trial on over 1000 patients. Int J Clin Pharmacol Ther Toxicol 31 (1993) 103-123
133. Cook J.D., Carriaga M., Kahn S.G., Schack W., and Skikne B.S. Gastric delivery system for iron supplementation. Lancet 336 (1990) 1136-1139
134. Reddajah V.P., Prasanna P., Ramachandran K., Nath L.M., Sood S.U., Madan N., et al. Supplementary iron dose in pregnant anemia prophylaxis. Indian J Pediatr 65 (1989) 109-114
135. Milman N., Byg K.E., Bergholt T., and Ericsen L. Side effects of oral iron prophylaxis in pregnancy - myth or reality?. Acta Haematol 115 (2006) 53-57
136. Schümann K., Borch-Iohnsen B., Hentze M.W., and Marx J.J.M. Tolerable upper intakes for dietary iron set by the US Food and Nutrition Board. Am J Clin Nutr 76 (2002) 499-500
137. Troost F.J., Saris W.H.M., Haenen G.R.M.M., Bast A., and Brummer R.-J.M. New method to study oxidative damage and antioxidants in the human small bowel effects of iron application. Am J Gastrointest Liver Physiol 285 (2003) G354-G359
138. Troost F.J., Brummer R.J.M., Haenen G.R.M.M., Bast A., van Haaften R.I., Evelo C.T., et al. Gene expression in human small intestinal mucosa in vivo is mediated by iron-induced oxidative stress. Physiol Genet 25 (2006) 242-249
139. Lund E.J., Wharf S.G., Fairweather-Tait S.J., and Johnson I.T. Oral ferrous sulfate supplements increase the free radical generating capacity of feces from healthy volunteers. Am J Clin Nutr 69 (1999) 250-255
140. Lund E.K., Fairweather-Tait S.J., Wharf S.G., and Johnson I.T. Chronic exposure to high levels of dietary iron fortification increases lipid peroxidation in the mucosa of the rat large intestine. J Nutr 131 (2001) 2928-2931
141. Babbs C.F. Free radicals and the etiology of colon cancer. Free Radical Biol Med 8 (1990) 191-200
142. Siegers C.P., Bumann D., Baretton G., and Younes M. Dietary iron enhances the tumor rate in dimethyldihydrazine-induced colon carcinogenesis in mice. Cancer Lett 41 (1988) 251-256
143. Nelson R.L., Yoo J.C., Tanure J.C., Andrianopoulos G., and Misumi A. Effect of iron on experimental colorectal carcinogenesis. Anticancer Res 9 (1989) 1477-1482
144. Porres J.M., Stahl C.H., Cheng W.H., Fu Y., Roneker K.R., Pond W.G., et al. Dietary intrinsic phytate protects colon from lipid peroxidation in pigs with a moderately high iron intake. Proc Soc Exp Biol Med 221 (1999) 80-86
145. Tseng M., Greenberger E.R., Sandler R.S., Baron J.A., Haile R.W., Blumberg B.S., et al. Serum ferritin concentration and recurrence of colorectal adenoma. Cancer Epidemiol Biomarker Prev 9 (2000) 625-630
146. Levi F., Pasche C., Lucchini F., and La Vecchia C. Selected micronutrients and colorectal cancer. A case-control study from canton Vaud, Switzerland. Eur J Cancer 36 (2000) 2115-2119
147. Kato I., Dnistrian A.M., Schwartz M., Toniolo P., Koenig K., Shore R.E., et al. Iron intake, body iron stores and colorectal cancer risk in women: a nested case-control study. Int J Cancer 80 (1999) 693-698
148. Deneo-Pellegrini H., De Stefani E., Boffetta P., Ronco A., and Mendilaharsu M. Dietary iron and cancer of the rectum: a case-control study in Uganda. Eur J Cancer Prev 8 (1999) 501-508
149. Wurzelmann J.I., Silver A., Schreinemachers D.M., Sandler R.S., and Everson R.B. Iron intake and the risk of colorectal cancer. Cancer Epidemiol Biomark Prev 5 (1996) 503-507
150. Nelson R.L., Davis F.G., Sutter E., Sobin L.H., Kikendall J.W., and Bower P. Body iron stores and risk of colonic neoplasia. J Natl Cancer Inst 86 (1994) 455-460
151. Nelson R.L., Davis F.G., Persky V., and Becker E. Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 76 (1995) 875-879
152. Gera T., and Sachdev H.P.S. Effect of iron supplementation on incidence of infectious illness in children: systematic review. Br Med J 325 (2002) 1142-1152
153. Olsen A., Nawiri J., and Friis H. The impact of iron supplementation on reinfection with intestinal helminths and Schistosoma mansoni in western Kenya. Trans R Soc Trop Med Hyg 94 (2000) 493-499
154. Engle J.P., Polin K.S., and Stile I.L. Acute iron intoxication: treatment controversies. Drug Intell Clin Pharm 21 (1987) 153-159
155. Sempos C.T. Do body iron stores increase the risk of developing coronary heart disease?. Am J Clin Nutr 76 (2002) 501-503
156. Kiechl S., Willeit J., Egger G., Poewe W., and Oberhollenzer F. Body iron stores and the risk of carotide atherosclerosis. Circulation 96 (1997) 3300-3307
157. Salonen J.T., Nyyssönen K., Korpela H., Tuomilehto J., Seppänen R., and Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men. Circulation 86 (1992) 803-811
158. Salonen J.T., Nyyssönen K., and Salonen R. Body iron stores and risk of coronary heart disease (letter). N Engl J Med 334 (1994) 1159
159. Danesh J., and Appleby P. Coronary heart disease and iron status: meta-analysis of prospective studies. Circulation 99 (1999) 852-854
160. Klipstein-Grobusch K., Koster J.F., Grobbee D.E., Lindemans J., Boeing H., Hofman A., et al. Serum ferritin and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr 69 (1999) 1231-1236
161. Olivares M., Walter T., Cook J.D., Hertrampf E., and Pizarro. Usefulness of serum transferrin receptor and serum ferritin in diagnosis of iron-deficiency in infancy. Am J Clin Nutr 72 (2000) 1191-1195
162. Tuomainen T.-P., Punnonen K., Nyyssönen K., and Salonen J.T. Association between body iron stores and the risk of acute myocardial infarction in men. Circulation 97 (1998) 1461-1466
163. Ascherio A., Willett W.C., Rimm E.B., Giovannucci E.L., and Stampfer M.J. Dietary iron intake and risk of coronary disease among men. Circulation 89 (1994) 969-974
164. Morgan E.H. Transferrin, biochemistry, physiology, and clinical significance. Mol Aspects Med 4 (1981) 1-123
165. Jiang R., Manson J.E., Meigs J.B., Ma J., Rifai N., and Hu F.B. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291 (2004) 711-717
166. Jiang R., Ascherio A., Stampfer M.J., Willet W.C., and Hu F.B. Dietary iron intake and blood donations in relation to risk of type 2 diabetes in men: a prospective study. Am J Clin Nutr 79 (2004) 70-75
167. Bassett M.L., Halliday J.W., and Powell L.W. Value of hepatic iron measurements in early haemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology 6 (1986) 24-29
168. Johnson B.F. Haemochromatosis resulting from prolonged oral iron therapy. N Engl J Med 278 (1968) 1100-1101
169. Jalil S.S., and Barlow A.M. Haemochromatosis following prolonged iron ingestion. J Roy Soc Med 77 (1984) 690-692
170. Isaacson C., Seftel H.C., Keeley K.J., and Bothwell T.H. Siderosis in the Bantu: the relationship between iron overload and cirrhosis. J Lab Clin Med 58 (1961) 845-853
171. Niederau C., Fischer R., Purschel A., Stremmel W., Haussinger D., and Strohmeyer G. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110 (1996) 1107-1119
172. Niederau C., Fischer R., Sonnenberg A., Stremmel W., Trampisch H.J., and Strohmeyer G. Survival and causes of death in cirrhotic and non-cirrhotic patients with primary hemochromatosis. N Engl J Med 313 (1985) 1256-1262
173. Hsing A.W., McLaughlin J.K., Olsen J.H., Mettemkjan L., Wacholder S., and Fraumeni J.F. Cancer risk following primary hemochromatosis. A population-based cohort study in Denmark. Int J Cancer 60 (1995) 160-162
174. Stevens R.G., Jones Y., Micozzi M.S., and Taylor P.R. Body iron stores and the risk of cancer. N Engl J Med 319 (1988) 1047-1052
175. Stevens R.G., Graubard B.I., Micozzi M.S., Neriishi K., and Blumberg B.S. Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56 (1994) 364-369
176. Knekt P., Reunanen A., Takkunen H., Aromaa A., Heliöavaara M., and Hakulinen T. Body iron stores and risk of cancer. Int J Cancer 56 (1994) 379-382
177. Mandishona E., MacPhail A.P., Gordeuk V.R., Kedda M.A., Paterson A.C., Rouault T.A., et al. Dietary iron overload as a risk factor for hepatocellular carcinoma in Black Africans. Hepatology 27 (1998) 1563-1566
178. Francanzani A.L., Conte D., Fraquelli M., Toioli E., Mattioli M., and Fargion S. Increased cancer risk in a cohort of 230 patients with hereditary hemochromatosis in comparison to matched control patients with non-iron-related chronic liver diseases. Hepatology 33 (2001) 647-651
179. Okada S., and Midorikawa O. Induction of renal adenocarcinoma by Fe-nitrilotriacetate (Fe-NTA). Jpn Arch Intern Med 29 (1982) 385-401
180. Toyokuni S., Uchida K., Okamoto K., Hattori Y., Nakakuki Y., Hiai H., et al. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen ferric nitrilotriacetate. Proc Soc Acad Sci USA 91 (1994) 2616-2620
181. Toyokuni S. Iron-induced cancerogenesis: the role of redox regulation. Free Radical Biol Med 20 (1996) 553-566
182. Zhang D., Okada S., Yu Y., Pingdong Z., Yamaguchi R., and Kasai H. Vitamin E, inhibits apoptosis, DNA modification and cancer induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 57 (1997) 2410-2414
183. Bullen J.J., Rogers H.J., and Griffiths E. Role of iron in bacterial infection. Curr Top Microbiol Immunol 80 (1978) 1-35
184. Cornelissen C.N., and Sparling P.F. Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol 14 (1994) 843-850
185. Barry D.M.J., and Reeve A.W. Increased incidence of Gram-negative neonatal sepsis with intramuscular iron administration. Pediatrics 60 (1977) 908-912
186. Farmer K., and Becroft D.M.O. Administration of parenteral iron to newborn infants. Arch Dis Cild 51 (1976) 500-501
187. Saarinen U.M., and Siimes M.A. Developmental changes in serum iron, total iron-binding capacity, and transferrin saturation in infancy. J Pediatr 91 (1977) 875-877
188. Kanakakorn K., Cavill I., and Jacobs A. The metabolism of intravenously administered iron-dextrane. Br J Haematol 25 (1973) 637-643
189. Becroft D.M.O., Dix M.R., and Farmer K. Intramuscular iron-dextrane and susceptibility of neonates to bacterial infections. Arch Dis Child 52 (1977) 778-781
190. Heresi G., Pizarro F., Olivares M., Cayazzo M., Hertrampf E., Walter T., et al. Effect of supplementation with an iron-fortified milk on incidence of diarrhea and respiratory infection in urban-resident infants. Scand J Infect Dis 27 (1995) 385-389
191. Power H.M., Heese H., De V., Beatty D.W., Hughes J., and Dempster W.S. Iron fortification of infant formula: the effect on iron status and immune function. Ann Trop Paediatr 11 (1991) 57-66
192. Hemminki E., Nemet K., Horvath M., Malin M., Schuler D., and Hollan S. Impact of iron fortification of milk formulas on infant growth and health. Nutr Res 15 (1995) 491-503
193. Mebrathu T., Stoltzfus R., Chwaya H.M., Jape J.K., Savioli L., Montresor A., et al. Low-dose iron supplementation for 12 months does not increase the prevalence of malarial infection for density of parasites in young Zanzibari children. J Nutr 134 (2004) 3037-3041
194. Allen S.J., O'Donnel, Alexander N.D.E., Alpers M.P., Peto T.E.A., Cleqg J.B., et al. Thallassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 94 (1997) 14736-14741
195. Stoltzfus R.J., and Dreyfuss M.L. Guidelines for the use of iron supplements to prevent and treat iron deficiency anemia (1998), ILSI Press, Washington, DC
196. Erhardt J.G., Estes J.E., Pfeiffer C.M., Biesalski H.K., and Craft N.E. Combined measurement of ferritin, soluble transferrin receptor, retinal binding protein, and C-reactive protein by an inexpensive, sensitive and simple sandwich enzyme-linked immunoabsorbtion assay technique. J Nutr 134 (2004) 3127-3132
197. Berger J., Dyck J.L., Galan P., Aplogan A., Schneider D., Taissac P., et al. Effect of daily iron supplementation on iron status, cell-mediated immunity and incidence of infections in 6-36 month old Togolese children. Eur J Clin Nutr 54 (2000) 29-35
198. Galy B., Ferring D., Minana B., Bell O., Janser H.G., Muckenthaler M., et al. Altered body iron distribution and microcytosis in mice deficient of Iron-Regulatory Protein 2 (IRP2). Blood 106 (2005) 2580-2589
199. Scientific Committee on Food. Tolerable upper intake levels for vitamins and minerals (2006), European Food Safety Authority, Parma p. 325-46
200. Elsenhans B., Schümann K., and Forth W. Toxic metals: interaction with essential metals. In: Rowland I.R. (Ed). Nutrition, toxicity, and cancer (1991), CRC Press, Boca Raton, Ann Arbor, Boston, London 223-258
201. Lynch S.R. Iron. In: Solomons N.W., and Rosenberg I.C.H. (Eds). Absorption and malabsorption of mineral nutrients (1984), Alan R Liss Inc., New York 89-124